| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/25/2008 | EP1173180B1 Camptothecin analogs and methods of preparation thereof |
| 06/25/2008 | EP1117687B1 Compositions and methods for wt1 specific immunotherapy |
| 06/25/2008 | EP1107789B1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/25/2008 | EP1041991B1 Non antibacterial tetracyclins for the treatment of multiple sclerosis |
| 06/25/2008 | EP0986382B1 Raf kinase inhibitors |
| 06/25/2008 | EP0942915B1 Pharmaceutical formulations |
| 06/25/2008 | EP0851920B1 Variants of vascular endothelial cell growth factor, their uses, and processes for their porduction |
| 06/25/2008 | CN101208356A Cancer specific PCNA isoform binding antibodies and uses thereof |
| 06/25/2008 | CN101208339A Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents |
| 06/25/2008 | CN101208338A Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents |
| 06/25/2008 | CN101208336A Thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents |
| 06/25/2008 | CN101208335A Pyrazole derivatives, their manufacture and their use as pharmaceutical agents |
| 06/25/2008 | CN101208332A Quinazoline derivatives as inhibitors of egf and/or erbb2 receptor tyrosine kinase |
| 06/25/2008 | CN101208331A Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors |
| 06/25/2008 | CN101208325A Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents |
| 06/25/2008 | CN101208312A Method of synthesis of anastrozole and purification of one of its intermediate |
| 06/25/2008 | CN101208310A New crystal forms of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide |
| 06/25/2008 | CN101208106A Cancer therapeutic agent |
| 06/25/2008 | CN101208087A Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 06/25/2008 | CN101208086A Indoloquinone tumor radiation sensitization |
| 06/25/2008 | CN101208079A Methods of suppressing UV light-induced skin carcinogenesis |
| 06/25/2008 | CN101208075A Liposome composition for induction of immunity |
| 06/25/2008 | CN101205544A Tumor targeting recombinant newcastle disease viruses and construction method thereof |
| 06/25/2008 | CN101205255A Anti CD20 tetravalent antibody, preparation method and uses thereof |
| 06/25/2008 | CN101205252A Soluble V E G F R bifunctional chimera receptor, preparation method and uses thereof |
| 06/25/2008 | CN101205244A Bimetallic heptanuclear anticancer compounds as well as preparation and uses thereof |
| 06/25/2008 | CN101205234A Curcumin-zinc compound as well as solid dispersion preparation and uses thereof |
| 06/25/2008 | CN101205233A Dimeric flavone compound as well as preparation and uses thereof |
| 06/25/2008 | CN101205231A Tetrahydroisoquinoline derivatives having multi-medicine resistance regulation activity and synthesis thereof |
| 06/25/2008 | CN101205218A Substituted cinnamyl piperazine as well as preparation and uses thereof |
| 06/25/2008 | CN101204584A Tumor vaccine using salmonella as carrier and preparation method thereof |
| 06/25/2008 | CN101204583A Application of PDCD4 regroup expression vector on process for preparing medicine curing glioma |
| 06/25/2008 | CN101204578A Extrasin combinationpreparation for immunomodulation, preventing tissue damage and reparative regeneration |
| 06/25/2008 | CN101204552A Chinese traditional medicine composite for breast cancer and cervical carcinoma and preparation method thereof |
| 06/25/2008 | CN101204551A Xiaobaidan capsule for leukemia |
| 06/25/2008 | CN101204538A Chinese traditional medicine preparation for stomach malignancy |
| 06/25/2008 | CN101204528A Chinese traditional medicine preparation for tumour |
| 06/25/2008 | CN101204521A Peroral Chinese traditional medicine prescription for leukemia |
| 06/25/2008 | CN101204497A Peroral Chinese traditional medicine for aplastic anemia |
| 06/25/2008 | CN101204486A Ointment for tumour |
| 06/25/2008 | CN101204463A Medicine for uterine cancer |
| 06/25/2008 | CN101204437A Chinese traditional medicine health product easing oesophagus malignancy |
| 06/25/2008 | CN101204405A Extractive of locust tree microellobosporia, preparation method and uses thereof |
| 06/25/2008 | CN101204402A Vacuum freezing and drying technology for leech |
| 06/25/2008 | CN101204401A Sea hedgehog extractive, preparation method and anticancer application thereof |
| 06/25/2008 | CN101204390A Paclitaxel mainline menstruum and application programme thereof |
| 06/25/2008 | CN101204382A Mitomycin double sustained release film of implanted antineoplastic agents and its preparation method |
| 06/25/2008 | CN101204376A Oxaliplatin freeze-dried powder and injection preparation method thereof |
| 06/25/2008 | CN101204373A Paclitaxel lipid microspheres injection and preparation method thereof |
| 06/25/2008 | CN101204370A Zolinza sustained-release implant treating for solid tumor |
| 06/25/2008 | CN101204369A Sorafenib sustained-release implant treating for solid tumor |
| 06/25/2008 | CN101204368A Pirarubicin sustained-release implant treating for solid tumor |
| 06/25/2008 | CN101204367A Axitinib sustained-release implplant treating for solid tumor |
| 06/25/2008 | CN101204366A Melphalan sustained-release implant treating for solid tumor |
| 06/25/2008 | CN101204365A Implant agent treating for solid tumor |
| 06/25/2008 | CN100397081C Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy |
| 06/25/2008 | CN100396700C Recombinant fusion protein of mycobacterium tuberculosis Ag85B antigen and human IL-2, and its uses |
| 06/25/2008 | CN100396698C New mastocancer related protein and its specificity multiclone antibody |
| 06/25/2008 | CN100396697C New mastocancer related protein and its specificity multiclone antibody |
| 06/25/2008 | CN100396696C Use of ocean green algae in extraction of cyclic peptide components with anti-tumor activity |
| 06/25/2008 | CN100396683C Pyrrolobenzodiazepines |
| 06/25/2008 | CN100396682C Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/25/2008 | CN100396677C 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 06/25/2008 | CN100396670C N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors, its pharmaceutical composition and use |
| 06/25/2008 | CN100396286C Use of homoharringtonine and harringtonine in inhibiting vascularization |
| 06/25/2008 | CN100396280C Application of asafetida and volatile asafetida oil in preparing anticancer medicine |
| 06/25/2008 | CN100396277C Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid |
| 06/25/2008 | CN100396276C Compositions containing organic compounds |
| 06/24/2008 | US7390924 Terphenyl derivatives, preparation thereof, compositions containing same |
| 06/24/2008 | US7390898 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 06/24/2008 | US7390895 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies |
| 06/24/2008 | US7390885 Humanized collagen antibodies and related methods |
| 06/24/2008 | US7390882 Compositions and methods for the diagnosis and treatment of tumor |
| 06/24/2008 | US7390832 Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment |
| 06/24/2008 | US7390828 Aminoderivatives of biotin and their conjugates with macrocyclic chelating agents |
| 06/24/2008 | US7390826 Inhibitors of animal cell motility and growth |
| 06/24/2008 | US7390818 3-(2,4-dimethoxyphenyl)-1,9-dimethyl-2-oxo-2,9-dihydro-1H-pyrido[2,3-b]indole-6-carboxylic acid; gamma-aminobutyric acid modulator; anticarcinogenic, antitumor, antiproliferative agent |
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/24/2008 | US7390805 Tyrosine kinase inhibitors; antiproliferative agents; antitumor agents |
| 06/24/2008 | US7390791 Prodrugs of phosphonate nucleotide analogues |
| 06/24/2008 | US7390668 Halogenated xanthan compound |
| 06/24/2008 | US7390658 Lymphoid dendritic cells generated from hematopoietic stem cells which encode viricidal and antitumor agents for preventing tumor metastasis and viral infection; immunotherapy |
| 06/24/2008 | US7390634 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation |
| 06/24/2008 | US7390633 Methods for preparing low molecular weight heparin with modified heparinase III |
| 06/24/2008 | US7390629 Tumor-activated prodrug compounds and treatment |
| 06/24/2008 | US7390625 Apoptosis-associated protein and use thereof |
| 06/24/2008 | US7390519 Probiotic Lactobacillus salivarius strains |
| 06/24/2008 | US7390510 Water soluble complex of hypericin and a polyvinylpyrrolidone; diagnosing and treating tumors |
| 06/24/2008 | US7390502 Administering a mammalian host for treating a disease caused by proliferation of eukaryotic cells a formulation containing a complex of lipid and a drug 7-ethyl-10-hydroxycamptothecin |
| 06/24/2008 | US7390488 Administering platelet binding agent; complexing; activation of complex; thrombosis |
| 06/24/2008 | US7390483 Modified by introduction of nucleic acid molecule comprising a nucleic acid sequence encoding granulocyte macrophage-colony stimulating factor (GM-CSF) operably linked to a promoter; contains cancer antigen; immunotherapy |
| 06/24/2008 | US7390411 Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid |
| 06/19/2008 | WO2008073785A2 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 06/19/2008 | WO2008073733A1 Salts of inhibitors of histone deacetylase for the treatment of disease |
| 06/19/2008 | WO2008073660A1 Molecules and methods for treatment and detection of cancer |
| 06/19/2008 | WO2008073509A2 Compositions and methods for treating a neoplasm |
| 06/19/2008 | WO2008073480A1 Compounds and compositions as kinase inhibitors |
| 06/19/2008 | WO2008073395A2 Compositions and methods for cardiac tissue protection and regeneration |
| 06/19/2008 | WO2008073306A1 Organic compounds |